ArticleDiscover oncology2024

AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer.

Rong-Sheng Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.